Safety and Efficacy of Pre-defined, Fixed Dose of Gonal-f Pen Based on Subject Baseline Characteristics in Subjects Undergoing in Vitro Fertilization (IVF)

NCT00249834 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

166

Enrollment

INDUSTRY

Sponsor class

Conditions

Infertility

Interventions

DRUG: Gonal-f
DRUG: Recombinant human chorionic gonadotrophin (r-hCG)

Sponsor

Merck KGaA, Darmstadt, Germany